Abraxis Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABRAXIS PHARM
ABRAXIS PHARM has one hundred and thirteen approved drugs.
Summary for Abraxis Pharm
| US Patents: | 0 |
| Tradenames: | 64 |
| Ingredients: | 60 |
| NDAs: | 113 |
Drugs and US Patents for Abraxis Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | DACARBAZINE | dacarbazine | INJECTABLE;INJECTION | 070962-001 | Aug 28, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | SODIUM HEPARIN | heparin sodium | INJECTABLE;INJECTION | 017033-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Abraxis Pharm | BACTERIOSTATIC SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | sodium chloride | SOLUTION;INJECTION | 088909-001 | Feb 7, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
